Eden Research plc (LON:EDEN – Get Free Report) shares rose 2.8% during mid-day trading on Tuesday following insider buying activity. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). Approximately 12,234,783 shares were traded during mid-day trading, an increase of 664% from the average daily volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey bought 540,540 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,919.32).
Eden Research Price Performance
The business’s 50 day moving average is GBX 3.89 and its two-hundred day moving average is GBX 4.01. The firm has a market capitalization of £20.80 million, a PE ratio of -200.00 and a beta of 0.92. The company has a debt-to-equity ratio of 1.25, a current ratio of 3.80 and a quick ratio of 2.42.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Featured Stories
- Five stocks we like better than Eden Research
- Why Are These Companies Considered Blue Chips?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Investing in Construction Stocks
- 3 Steel Stocks Soaring After Tariff Announcements
- Consumer Staples Stocks, Explained
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
